Search

everythinglearnresearchcommunity

for

Search:↓

Hirsutism in women often indicates a hormonal imbalance and can be managed with a combination of hormonal treatments and hair removal methods.

Managing side effects of endocrine therapy is crucial to improve adherence and survival in breast cancer patients.

Drugs can change hair growth and this is important because it can upset people.

Antiandrogens, particularly flutamide and CPA, are most effective for treating hirsutism, with long-term use needed for best results.

High-dose dutasteride reduces PMDD symptoms by stabilizing neurosteroid levels.

The document concludes that early recognition and treatment of PCOS in adolescents is crucial for managing symptoms and long-term health risks.

Cyproterone acetate is the preferred treatment for women's hyperandrogenism when estrogen/progestogen use is safe.

With careful management, people with congenital adrenal hyperplasia can have successful pregnancies and become parents.

The document says that understanding the causes of PCOS is important for treatment, especially in distinguishing the syndrome from just having cystic ovaries, and that losing weight is key for obese women with PCOS.

Non-invasive imaging helped diagnose a woman's severe hormone imbalance and diabetes, and medication successfully treated her condition.

People with polycystic ovary syndrome often have low levels of vitamin D.

The document concludes that treating androgen excess needs patience, managing expectations is important, and many drugs used are not officially approved, suggesting cosmetic options for mild cases.

Cimetidine did not reduce hair growth in women with hirsutism.

Different anti-androgen medications can help treat excessive hair growth, but the right choice depends on accurate diagnosis.

Hormonal treatments can help with acne, especially in women, by lowering androgen levels or blocking their effects.

The study found three different timing patterns of symptoms in women with premenstrual dysphoric disorder.

The conclusion is that while oral contraceptive pills are effective for PCOS-related high androgen levels, new treatments with fewer side effects are needed.

Polycystic Ovary Syndrome likely starts in childhood and may be genetic and influenced by early hormone exposure.

Exemestane is effective and safe for treating certain breast cancers, with mild side effects, but needs more research on long-term effects.

Polycystic ovary syndrome costs the U.S. over $4 billion a year, mainly from treating related health issues.

Most women referred for excess male hormone symptoms had polycystic ovary syndrome (PCOS), with other conditions being less common.

Hormone therapy for excessive hair growth is as good with GnRHa as with high-dose CPA, but GnRHa has longer-lasting results.

The conclusion is that managing androgen excess requires long-term treatment, including hormonal contraceptives and androgen blockers, with follow-up after six months.

New hormonal contraceptives are safer, have fewer side effects, and offer health benefits for women.

The document concludes with guidance for doctors on diagnosing and treating hirsutism effectively and safely.

Flutamide effectively reduced excessive hair growth and improved related symptoms in hirsutism patients without significant side effects.

The update highlights that non-classic congenital adrenal hyperplasia is common in women with excess male hormones, requires specific hormone tests for diagnosis, and has various treatment options depending on age and symptoms.

Multimodal primary treatment improves survival in premenopausal breast cancer patients and is also beneficial for postmenopausal women.

Different treatments for Hidradenitis suppurativa range from antibiotics and hormonal therapies to surgery, depending on severity.